- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$1.58 BnMarket Estimate, 2026
$1.71 BnMarket Forecast, 2034
$3.28 BnCAGR, 2026–2034
8.49%Executive Summary: Europe Infusion Pump Market
- Market Scope: Regional analysis of Europe's infusion pump sector, detailing device and accessory types, clinical applications, healthcare end-users, and country-level profiles.
- Market Valuation: Valued at USD 1.58 billion in 2025, reaching USD 1.71 billion in 2026, and projected to expand to USD 3.28 billion by 2034, growing at a robust CAGR of 8.49% from 2026 to 2034.
- Primary Growth Drivers: Rising prevalence of chronic diseases (such as diabetes and cancer), growing aging population, increasing surgical procedures, and expansion of intensive care units.
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Type | Accessories & Consumables (dominated in 2025, driven by regular replacement cycles and tubing/syringe usage) | Devices (anticipated at high growth, fueled by capital investments in smart and connected infusion systems) |
| By Product | Volumetric & Syringe Infusion Pumps (held dominant share in 2025, anchored by critical hospital care and ICU deployment) | Ambulatory & Insulin Infusion Pumps (expected to register strong growth driven by home care and portable therapy needs) |
| By Application | Diabetes & Chemotherapy/Oncology (captured major market share in 2025, supported by chronic disease burdens) | Analgesia / Pain Management (projected at high growth, propelled by patient-controlled analgesia adoption) |
| By End-User | Hospitals (held dominant market share in 2025, backed by high surgical volumes and intensive care admissions) | Home Care Settings (expected to register highest CAGR driven by decentralized care and patient mobility trends) |
| By Country | Germany & UK (market leaders with substantial shares in 2025, backed by advanced healthcare infrastructure and smart device deployment) | France, Italy & Spain (key regional hubs driven by health modernization and chronic disease management initiatives) |
Major Market Players & Industry Landscape
Market Structure: Highly competitive medical technology environment characterized by global medical device manufacturers supplying smart infusion systems, software, and consumables to acute and home care settings.
Key Companies: BD, B. Braun Melsungen AG, Baxter, Fresenius Kabi AG, ICU Medical, Inc., Smiths Group PLC, Medtronic, Moog Inc., Terumo Corporation, Avanos Corporate, NIPRO, Insulet Corporation, Tandem Diabetes Care, Inc., JMS Co. Ltd., and F. Hoffmann-La Roche Ltd.
Download Free Sample Report
Europe Infusion Pump Market Size
The European infusion pump market size was valued at USD 1.58 billion in 2025 and is anticipated to reach USD 1.71 billion in 2026 from USD 3.28 billion by 2034, growing at a CAGR of 8.49% during the forecast period from 2026 to 2034.
The growing population suffering from chronic diseases and the increasing geriatric population across Europe are majorly boosting the growth of the infusion pump market in Europe. The infusion pump is a medical device that helps to deliver fluids such as nutrients and medications such as insulin or other hormones, antibiotics, drugs, and pain relievers. Some types of infusion pumps are patient-controlled analgesia, syringes, insulin pump, and elastomeric. Cardiovascular disease, diabetes, and cancer are the most common chronic diseases in many populations. As per a recent survey, nearly 61 million population are suffering from diabetes in Europe region. For diabetic people, healthcare providers use infusion pumps to keep steady glucose levels, delivering the drug to the patient without any error. Infusion pumps are also used for cancer patients who need continuous chemotherapy treatment to prevent cancer or abnormal cell growth in the body. For the chemotherapy process, a controlled number of drugs should be sent to the bloodstream, which can be done through infusion pumps.
The growing number of surgical procedures happening and an increasing number of intensive care units across Europe are further fuelling the infusion pump market growth in Europe. Owing to the increasingly critical situation during the surgeries, the healthcare provider prefers to use infusion pumps for the patient to inject a certain amount of drug to reduce any side effects and dehydration problems. Increasing use of home-based infusion pumps to take treatment also demands the market. Most of the older population and disabled people are using home infusion pumps by healthcare specialists for a fast cure of the disease.
The rising number of R&D activities to innovate and manufacture advanced infusion pumps is propelling the infusion pump market growth in Europe. Many key players are focusing on developing ambulatory infusion pumps, which will increase their demand during the forecast period. In addition, the developer has designed several applications or software that show the dosage levels of the medications during the procedures. Increasing research and development and increasing pharmaceutical support are other factors for market growth.
On the other hand, the high cost of infusion pumps is the primary factor that restrains the market growth during the forecast period. In addition, increases in medication errors, lack of wireless connectivity, strict regulatory requirements of new products, lack of proper infrastructure, and lack of skilled professionals hamper the market growth in this region.
REGIONAL ANALYSIS
Europe held a substantial share of the worldwide market in 2024 and is estimated to grow at a promising CAGR during the forecast period owing to the rapid adoption of advanced technologies in the healthcare sector. In addition, increasing the adoption of infusion pumps by hospitals, nursing homes, care centers, and clinics also helps with the demand for market growth.
The UK market accounted for a notable share of the European market during the forecast period owing to the increasing development of smart infusion pumps in the country. As per the report by the National Patient Safety Agency in England, there is an increase in death or critical life situations due to injectable medicine. Several studies have also been conducted in United Kingdom hospitals to check the rate of infusion errors. To reduce this error, regional manufacturers focus on developing smart infusion devices to deliver drugs to patients. These smart infusion pumps include features such as a sensor, a battery system, and backup power.
Germany held a considerable share of the European market in 2024 and is expected to grow at a promising CAGR during the forecast period.
KEY MARKET PLAYERS
Companies playing a prominent role in the European infusion pump market profiled in this report are BD, B. Braun Melsungen AG, Baxter., Fresenius Kabi AG, ICU Medical, Inc., Smiths Group PLC, Medtronic, Moog Inc., Terumo Corporation, Avanos Corporate., NIPRO, Insulet Corporation, Tandem Diabetes Care, Inc., JMS Co.Ltd. and F. Hoffmann-La Roche Ltd.
MARKET SEGMENTATION
This market research report on the Europe infusion pump market has been segmented and sub-segmented into the following categories.
By Type
- Accessories and Consumables
- Devices
By Product
- Volumetric infusion pumps
- Insulin infusion pumps
- Enteral infusion pumps
- Ambulatory infusion pumps
- Syringe infusion pumps
- Patient-controlled analgesia (PCA) pumps
- Implantable infusion pumps
By Application
- Chemotherapy/Oncology
- Diabetes
- Gastroenterology
- Analgesia/pain management
- Pediatrics/neonatology
- Hematology
- Other applications
By End-User
- Hospitals
- Home care settings
- Ambulatory care settings
- Academic and research institutes
By Country
- UK
- France
- Spain
- Germany
- Italy
- Russia
- Sweden
- Denmark
- Switzerland
- Netherlands
- Turkey
- Czech Republic
- Rest of Europe